Andrew Roughton

Vice President Discovery & Operations
Encycle Therapeutics
Nina E. Weisser
Andrew Roughton is VP, Discovery & Operations at Encycle Therapeutics (Toronto), investigating macrocycles for therapeutic intervention. He worked previously with Dalton MedChem (Toronto) and Pharmacopeia, Inc. (Princeton) on small molecule drug discovery and development for a broad range of target classes and indications. His training is in organic chemistry with P. Deslongchamps (Sherbrooke), M. Demuth and K. Schaffner (Max-Planck-Institut, Mlheim) and S. A. Benner (ETH Zrich).


No data was found